Press release content from Business Wire. The AP news staff was not involved in its creation.
Origin Materials and AECI SANS Technical Fibers to Develop Carbon-Negative Materials for Apparel and Automotive Applications
April 5, 2021 GMT
WEST SACRAMENTO, Calif. & GREENSBORO, N.C. (BUSINESS WIRE) Apr 5, 2021
Origin Materials, Inc. (“Origin Materials”), the world’s leading carbon negative materials company, and AECI SANS Technical Fibers (“SANS”), a leader in engineered thread for high-performance apparel and automotive applications, today announced an expansion of their partnership in order to develop, industrialize and manufacture advanced materials built on the Origin Materials’ carbon-negative technology platform.
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
Moderna Provides Storage Update & Announces the U.S. FDA Authorizes Up To 15-Doses Per Vial of its COVID-19 Vaccine
April 2, 2021 GMT
CAMBRIDGE, Mass. (BUSINESS WIRE) Apr 1, 2021
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that based on submitted stability data, the U.S. Food and Drug Administration (FDA) has authorized the Moderna COVID-19 Vaccine to be kept at room temperature conditions once removed from the refrigerator for administration for 24 hours, an increase from the previous 12 hours. Additionally, a punctured vial is now useable for up to 12 hours, an increase from the previous 6 hours. These new guidelines are reflected in an updated Emergency Use Authorization (EUA) label. The Moderna COVID-19 Vaccine is ready for use and does not need to be diluted.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Adalimumab: Sold Under the Brand Name Humira - Global Biosimilar Insight Report 2021 - ResearchAndMarkets.com
April 2, 2021 GMT
The “Adalimumab - Biosimilar Insight, 2021” report has been added to ResearchAndMarkets.com’s offering.
This “Adalimumab - Biosimilar Insight, 2021,” report provides comprehensive insights about 34+ companies and 35+ marketed and pipeline drugs in Adalimumab Biosimilars landscape.
ADVERTISEMENT
It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Fresenius Kabi Signs Exclusive U.S. Distribution Agreement with Corvida Medical for the HALO® Closed System Drug-Transfer Device
April 1, 2021 GMT
Fresenius Kabi is now the exclusive U.S. distributor for Corvida Medical s HALO Closed System Drug-Transfer Device. (Photo: Business Wire)
Fresenius Kabi is now the exclusive U.S. distributor for Corvida Medical s HALO Closed System Drug-Transfer Device. (Photo: Business Wire)
LAKE ZURICH, Ill. (BUSINESS WIRE) Apr 1, 2021
Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, today announced it has signed an exclusive distribution agreement for the U.S. with Corvida Medical.
Press release content from Newswire. The AP news staff was not involved in its creation.
Zen-Noh Grain Corporation and Viserion Grain, LLC Announce Sale and Purchase Agreement of 11 Grain Facilities
April 1, 2021 GMT
COVINGTON, La. - April 1, 2021 - ( Newswire.com )
Zen-Noh Grain Corporation (ZGC) announced today that it has entered into an agreement with Viserion Grain, LLC (Viserion) for Viserion to acquire 11 grain facilities. These facilities are expected to be required by the U.S. Department of Justice to be divested in connection with its review of ZGC’s acquisition of multiple grain facilities from Bunge, a transaction announced spring of 2020. Both transactions remain subject to clearance from the U.S. Department of Justice, and the sale to Viserion is conditioned on the closing of the Bunge acquisition. Both transactions are expected to close late spring.